BINBIN YI: Open Payments
NPI 1619592466 · NAUGATUCK, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,212 in 41 payments from 15 companies in 2025. Trend: 2023 $487 · 2024 $684 · 2025 $1,212
Food & beverage: $1,117Education: $94
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 5 | $176 |
| Janssen Biotech, Inc. | 5 | $172 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $165 |
| Phathom Pharmaceuticals, Inc. | 3 | $162 |
| ABBVIE INC. | 5 | $125 |
| Gilead Sciences, Inc. | 5 | $108 |
| Baxter Healthcare | 1 | $104 |
| Madrigal Pharmaceuticals | 3 | $72 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| Novo Nordisk Inc | 1 | $22 |
Products named: IBSRELA, TREMFYA, VOQUEZNA, ENTYVIO, TISSEEL, REZDIFFRA, SKYRIZI, EOHILIA.
Industry payments across CT — which companies pay providers there.
